fnh肝局灶性結(jié)節(jié)性增生_第1頁(yè)
fnh肝局灶性結(jié)節(jié)性增生_第2頁(yè)
fnh肝局灶性結(jié)節(jié)性增生_第3頁(yè)
fnh肝局灶性結(jié)節(jié)性增生_第4頁(yè)
fnh肝局灶性結(jié)節(jié)性增生_第5頁(yè)
已閱讀5頁(yè),還剩20頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

Outline

FNHaccountsforapproximately8%ofallprimaryhepatictumorandisthesecondmostcommonbenignlivertumorafterhemangioma.

Thisbenigntumouroccursmostcommonlyinwomenaged20–50years,butmayoccurinbothmenandwomenatanyage,withmultiplelesionsbeingfoundin20percentofcases.FNH

Oralcontraceptive口服避孕藥useisassociatedwithFNHbuttheresponsibilityoforalcontraceptivesintheoccurrenceofthelesionhasnotbeendemonstrated.ClinicalsymptomsFNHisusuallyanincidentalfindingatimagingandonlyone-thirdarediscoveredbecauseofclinicalsymptomssuchasmildepigastricpainordiscomfortandorpalpableabdominalmass.Bloodlivertestsarenormalinhalfofthecasesandshowonlyincreasedinserumgamma-glutamyl-transpeptidase血清r-谷氨酰轉(zhuǎn)肽酶activityinmostoftheremnants.

well-circumscribedlobulatedmasswithcentralscar(arrow)andradiatingseptations.

PathologicalappearanceFNHisdefinedasanodulecomposedofbenign-appearinghepatocytesoccurringinaliverthatisotherwisehistologicallynormal.FNHisahyperplasticliverparenchyma(增生性肝實(shí)質(zhì))subdividedintonodulesbyfibrousseptathatmayformstellatescars(星狀瘢痕).Thelesionisusuallysolitary(80%)andmeasureslessthan5cmindiameter.Occasionally,FNHispedunculated(蒂).Photomicrographofhistopathologicspecimenshowsregionsofnodularhepatocellularproliferationseparatedbyradiatingbandsandsurroundingmyxomatousscar(arrows).Themarginissharp,oftenlobulatedandnocapsuleispresent.Hemorrhageandnecrosisarerare.Atmicroscopy,thecentralfibroticzoneisdenseconnectivetissue(致密結(jié)締組織)whichcontainsnumerousabnormallythickwalledarteries.Markedproliferationofbiliarystructuressurroundedbyinflammatorycellsisobservedwithinandattheperiphery(邊緣)ofthefibrousseptae.Kupffercellsarealsoseenwithinthelesion.FNHclassic(80%)non-classic(20%)

(a)telangiectaticFNH,

(b)withatypia,

(c)mixedhyperplasticandadenomatousFNH

Diagnosis(CT)NonenhancedCTscansFNHisdemonstratedasafocalhypodenseorisodensemasscomparedwithnormalliver.Acentralhypodensescarisdepictedinonlyone-thirdofthecases.Calcificationswithinthecentralscarareveryrareandobservedinonlyabout1%ofthecases.contrast-enhancedCTscanarterial

phaseThelesionenhancesrapidlyinmostcasesandthelesiontolivercontrastishigh.Lesioncontouriswelldemarcatedandmaybelobulated.Atthattime,thecentralscarishypodenseandappearsmoreevidentthanonunenhancedCTscans.

portalvenousphaselesionenhancementdecreasesandthelesionmaybeeitherisoorslightlyhyperdenserelativetonormalliver.Small-sizedFNHmaybebarelyvisible,whereaslarge-sizedFNHarevisualizedduetodeformityinthelivercontourordisplacementofadjacentvesselsordepictionofarelativelyhypoattenuatingcentralscar.

delayed

phase

FNHareisodenserelativetonormalliverandinmostcases,centralscarsappearisoorhyperattenuating.Acentralscarisobservedmoreofteninlargelesionsthaninsmalllesions.CTT1WIT2WI

Diagnosis(MRI)NonenhancedMRIscans

TypicalFNHsareisoorhypointenseonT1WIandisoorslightlyhyperintenseonT2WI.

ThecentralscarishypointenseonT1WI

andstronglyhyperintenseonT2WI.contrast-enhancedMRIscandramaticenhancementinthearterialphase,followedbyisointensityofthelesionduringtheportalvenousphase.Ondelayedphaseimaging,thecentralscarshowshighsignalintensity.Atypicalformsscarsareseeninmorethan80%ofcases.However,radio-pathologicpapershavedemonstratedthatsomeFNHmayhavenoscarevenatpathologyespeciallyFNHmeasuringlessthan3cmindiameter。Rarely,scarsremainhypodenseorisodenseondelayedscansorarehypointenseonT2-weightedimages.Thesefindingsmaybeobservedupto20%ofcases.NearlyallFNHsarehypervascularatthearterialphaseoftheenhancement,butlesionenhancementmayvaryattheportalphaseorondelayedimages.Bothhypodensityorintensityofthemassondelayedphase,oronbothportalveinanddelayedphaseimagesaswellashyperdensity-intensityofthemassontheportalveinphaseoronbothportalveinanddelayedphasesmaybeseen.AlthoughFNHisanon-encapsulatedlesion,capsulelikeenhancementmaybeobservedonportalveinandondelayedphasescansinabout25–36%ofthecases.Thepseudocapsule(假包膜)ishypointenseonT1andslightlyhyperintenseonT2.

Differentialdiagnosis肝囊腫Hepaticcyst

原發(fā)性肝癌primaryhepaticcarcinoma肝囊腫Hepaticcystnoncontrast-enhancedcontrast-e

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論